ANCA-negative pauci-immune glomerulonephritis must be one of the most challenging fields in vasculitis. In this commentary in @KIReports, we discuss some open questions on this topic.

www.kireports.org/article/S246...

Does plasma exchange have a role in ANCA-associated vasculitis? Viewpoint 2: plasma exchange may be useful under some circumstances Abstract. The use of plasma exchange (PLEX) as adjunct therapy in the initial management of anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculit

Recently, post-hoc analyses of the PEXIVAS trial have provided new insights into the use of PLEX in #AAV. In this viewpoint, we highlight clinical scenarios where its use may be benefical. Don’t miss „Viewpoint 1“ by Mike Walsh.

academic.oup.com/rheumatology...

Sometimes the most challenging cases seem to pop up on Friday when you’re on your own. We tried to collect some helpful points when dealing with these cases. @nephroneu.bsky.social @kathrineller.bsky.social @odlerb.bsky.social @ckj-era.bsky.social

The effects of plasma exchange and glucocorticoids on early kidney function among patients with ANCA-associated vasculitis in the PEXIVAS trial Therapeutic plasma exchange (PLEX) is an adjunctive treatment for patients with anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis and kidney involvement. Little is known about the effe...

Just published in @kidneyint.bsky.social. The impact of PLEX and GC on early kidney function changes in AAV. This analysis provides another important piece of the “PLEX puzzle”.

www.kidney-international.org/article/S008...